Handheld scanners and glucose monitors aim to catch diseases early

NCT ID NCT07209527

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether portable ultrasound and blood glucose monitors can help doctors catch chronic conditions like diabetes, heart disease, and kidney disease earlier than usual. About 200 adults will use these devices or receive standard care for 6 months. The goal is to see if the devices improve detection rates and patient outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Truway Portable Ultrasound Device and Truway Blood Glucose Monitor
What this could lead to
If successful, this could make early detection of chronic diseases easier and more accessible in primary care, potentially improving outcomes.
What could go wrong
This is an early-phase study with only 200 participants, so results may not apply broadly. The devices may not significantly improve detection over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASE ACUTE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Truway Health, Inc.

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.